COVID 01 Daley 508

Document text

cdc.gov/coronavirus
ACIP COVID-19 Vaccines Work Group
Dr. Matthew F. Daley, Work Group Chair
February 24, 2023
December 8, 2022: FDA1granted emergency use authorization (EUA) for:
–
–Use of Moderna bivalent COVID- 19 vaccine booster in children ages 6 months -5 years 
Use of Pfizer- B ioNTech bivalent COVID- 19 vaccine as a third primary series dose for 
children 6 months- 4 years of age
December 9, 2022: CDC2expanded the use of updated (bivalent) COVID- 19 
vaccines for children 6 months through 5 yearsCOVID-19 vaccine update:
Bivalent booster authorizations extended to children ages 6 months and older
21. https://www.fda.gov/news- events/press-announcements/coronavirus- covid -19-update- fda-authorizes-updated-bivalent- covid -19-vaccine s-children- down -6-months
2. https://www.cdc.gov/media/releases/2022/s1209- covid -vaccine.html
Epidemiology of COVID- 1 9, including MIS- C and hospitalization data 
Vaccine effectiveness (VE) updates
COVID -19 a mong persons with immunocompromise, including VE and Evusheld updates 
Discussions for inputs on cost effectiveness analyses 
COVID -19 v accine safety updates 
Review benefit/risk analysis
Updates to COVID- 19 vaccines in children 6 months through 5 years of age, including 
Moderna COVID-19 vaccine booster doses 
Ongoing work to increase uptake of bivalent COVID- 19 v accines
Considerations for transition to bivalent primary series
Future directions for COVID- 19 v accines  ACIP COVID-19 Work Group Meeting Review
October 2022– February 2023
3
COVID- 19 v accine safety updates: CDC Dr. Shimabukuro (CDC)
COVID- 19 v accine safety update: FDA Dr. Forshee (FDA)
VaST su mmary Dr. Talbot (ACIP , VaST )
Work Group interpretation and summary Dr . Twentyman (CDC)
Break
Updates on COVID -19 ho spitalizations in the US Dr. Taylor (CDC)
Updates to COVID -19 v accine effectiveness in the US Dr. Britton (CDC)
Considerations for transitioning to bivalent primary series Dr . Oliver (CDC)
Work Group interpretation and summary Dr . Twentyman (CDC)
Discussion
Break
Benefit- r isk analysis for COVID -19 vaccines Dr. Wallace (CDC)
COVID-19 vaccines: future directions Dr. Oliver (CDC)
DiscussionAgenda: Friday February 24, 2023
ACIP members
Matthew Daley (ch air)
Beth Bell 
Grace Lee
Keipp Talbot
Oliver Brooks
Ex-o
fficio/government members
FDA: Rachel Zhang, Lucia Lee, Anuja Rastogi
NIH: Chris Roberts
IHS: Uzo Chukwuma
CMS: Jeff Kelman
BARDA: Christine Oshansky
HHS: David Kim
CDC: Alan Lam
CDC L
eads
Sara Oliver
Evelyn TwentymanWork Group members
5LiaisonsAAFP: Jonathan Temte
AAP: Sean O’Leary
ACOG: Denise Jamieson (primary), 
La
ura Riley (alternate)
ACP: Jason Goldman
ADS: Emily Kahn
AGS: Ken Schmader
AIM: Rob Shechter (primary), J
ane Zucker (alternate)
AMA: Sandra Fryhofer
ANA: Ruth Francis (alternate)
APhA: Michael Hogue
ASTHO: Marcus Plescia
CSTE: Susan Lett, Paul Cieslak, Christine Ha
hn
IDSA: Jeff Duchin (primary)Liaisons, cont’d




NACCHO: Matt Zahn (primary), 
Jeff Duchin (alternate)
NACI: Matthew Tunis (primary),
Nicole Forbes (alternate)
NFID: Bill Schaffner (primary), Marla Dalton (alternate)
NMA: Patricia Whitley -Williams
SHEA: Marci Drees,
Preeti Mehrotra (alternate) 
C
onsultants

Ed Belongia
Kathy Kinlaw 
Dayna Matthew 
Kathleen N euzil
Stanley Perlman 
Peter S zilagyi
Hank Bernstein
Sarah Meyer
Elisha Hall
Megan Wallace
Danielle Moulia
Lauren Roper
Hannah Rosenblum
Katherine Fleming -D utra
Monica Godfrey
Susan Goldstein
Mary Chamberland
Stephen Hadler
JoEllen Wolicki
Melinda Wharton
Jessica MacNeil
Amanda CohnCDC participants
6Ruth Link -Gel les
Amadea Britton
Carolyn Bridges
Allison Ciesla 
Nicole Dowling
Ashley Fowlkes
Heather Scobie
Natalie Thornburg
Tom Shimabukuro
John Su
Julianne Gee
Karen Broder
Rita Helfand
Jefferson Jones
Yvonne BolenIsmael Ortega- San chez
Pragna Patel 
Amanda Payne
Georgina Peacock
Jose Romero
Laura Steinhardt
Ryan Wiegand
Patricia Yu
Yon YuSamuel Graitcer
Lisa Grohskopf
Katherine Grusich
Aaron Hall
Ebony Houston
Terri Hyde
Cynthia Jorgensen
Kristen Nordlund
Sierra Scarbrough
Edwin Shanley
Andrew Kroger
Lauri Markowitz
Noelle -An gelique Molinari
Michael McNeil
Morgan Najdowski
For more information, contact CDC
1-800-CDC- INFO (232- 4636)
TTY:  1 -888-232-6348    www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Thank you!